Physician profile
John Gerald Burvant
NPI 1124036223
$1,104.13
in general payments reported to CMS, 2019-2025
16 companies · $55.84 in 2025
The $55.84 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $148 · 2021: $159 · 2022: $46.47 · 2023: $330 · 2024: $73.32 · 2025: $55.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $467.83 | 2019-2023 | Accolade, Triathlon, Mako |
| Pacira Therapeutics, INC. | $208.73 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $65.19 | 2019-2022 | |
| Boston Scientific Corporation | $47.32 | 2020-2021 | |
| Vericel Corporation | $39.80 | 2020-2023 | Maci |
| Sanofi-Aventis U.S. LLC | $38.98 | 2019-2020 | |
| Bioventus LLC | $35.02 | 2022-2023 | Durolane |
| Amgen INC. | $32.76 | 2019-2024 | Evenity, Prolia |
| Biocomposites INC | $32.53 | 2025 | Stimulan |
| Organogenesis INC. | $30.58 | 2024 | |
| Convatec INC. | $23.31 | 2025 | |
| Radius Health, INC. | $23.02 | 2024 | |
| Horizon Therapeutics Plc | $17.85 | 2019 | |
| Baudax Bio INC. | $16.09 | 2022 | |
| Baxter Healthcare | $13.34 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burvant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.